Cardiac Resynchronization Therapy in a Patient with Hypertrophic Cardiomyopathy and Symptomatic Heart Failure with Preserved Ejection Fraction

被引：1
|
作者：
Leung, Christopher [1 ]
Fifer, Michael [2 ]
Singh, Jagmeet [2 ]
Parks'-, Kimberly [2 ]
机构：
[1] Boston Med Ctr, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
来源：
JOURNAL OF CARDIAC FAILURE | 2017年 / 23卷 / 08期
关键词：
D O I：
10.1016/j.cardfail.2017.07.200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
188
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [1] The hypertrophic cardiomyopathy - a particular cause of the heart failure with preserved ejection fraction
    Nowak, A. Alicja
    Oko-Samowska, Z.
    Kaluzna-Oleksy, M.
    Lesiak, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 315 - 315
  • [2] Heart Failure With Preserved Ejection Fraction in Hypertrophic Cardiomyopathy With and Without Septal Myectomy
    McGee, Katherine
    Chu, Stanley
    Choudhury, Lubna
    CIRCULATION, 2020, 142
  • [3] Clinical characteristics and prognosis of patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction
    Chen, Qin-Fen
    Hu, Jiandong
    Hu, Jie
    Nijjar, Prabhjot S.
    Xu, Jiahui
    Shi, Shanzhen
    Liang, Dongjie
    Liao, Hetong
    Gao, Jiaqi
    Lin, Wei-Hong
    You, Shenban
    Zhou, Xiao-Dong
    CLINICAL RESEARCH IN CARDIOLOGY, 2024, 113 (05) : 761 - 769
  • [4] Clinical characteristics and prognosis of patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction
    Qin-Fen Chen
    Jiandong Hu
    Jie Hu
    Prabhjot S. Nijjar
    Jiahui Xu
    Shanzhen Shi
    Dongjie Liang
    Hetong Liao
    Jiaqi Gao
    Wei-Hong Lin
    Shenban You
    Xiao-Dong Zhou
    Clinical Research in Cardiology, 2024, 113 : 761 - 769
  • [5] Mavacamten Allosteric modulator of cardiac myosin Treatment of hypertrophic cardiomyopathy Treatment of heart failure with preserved ejection fraction
    Gras, J.
    DRUGS OF THE FUTURE, 2021, 46 (06) : 443 - 450
  • [6] Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy
    Liu, Jie
    Wang, Dong
    Ruan, Jieyun
    Wu, Guixin
    Xu, Lianjun
    Jiang, Wen
    Wang, Jizheng
    Sun, Xiaolu
    Kang, Lianming
    Song, Lei
    BMC MEDICINE, 2022, 20 (01)
  • [7] Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy
    Jie Liu
    Dong Wang
    Jieyun Ruan
    Guixin Wu
    Lianjun Xu
    Wen Jiang
    Jizheng Wang
    Xiaolu Sun
    Lianming Kang
    Lei Song
    BMC Medicine, 20
  • [8] A Case of Cardiac Resynchronization Therapy for Heart Failure with Reduced Ejection Fraction
    Kupchik, Nicole
    Vance, Sarah
    AMERICAN JOURNAL OF NURSING, 2024, 124 (12) : 50 - 52
  • [9] Diagnosing heart failure with preserved ejection fraction in cardiac amyloidosis or diagnosing cardiac amyloidosis in heart failure with preserved ejection fraction?
    Lund, Lars H.
    Eldhagen, Per
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (12) : 2387 - 2389
  • [10] Is cardiac resynchronization therapy an option in heart failure patients with preserved ejection fraction? Justification for the ongoing KaRen project
    Donal, Erwan
    Lund, Lars
    Linde, Cecilia
    Daubert, Jean-Claude
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2010, 103 (6-7) : 404 - 410
12345